Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinoic Acid”

238 trials

Showing 20 of 238 results

Testing effectiveness (Phase 2)Ended earlyNCT00969722
What this trial is testing

MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients

Who this might be right for
Primary Refractory Neuroblastoma
United Therapeutics 1
Post-approval studies (Phase 4)Study completedNCT04548349
What this trial is testing

Profiling the Skin Microbiome in Response to Altreno in Acne Patients

Who this might be right for
AcneHealthy
Beth Israel Deaconess Medical Center 25
Post-approval studies (Phase 4)Ended earlyNCT00240513
What this trial is testing

Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin

Who this might be right for
Acne Vulgaris
Derm Research @ 888 Inc. 38
Testing effectiveness (Phase 2)Looking for participantsNCT06982274
What this trial is testing

Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia (APL)
Instituto do Cancer do Estado de São Paulo 115
Testing effectiveness (Phase 2)Looking for participantsNCT06528769
What this trial is testing

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Who this might be right for
LeiomyosarcomaSarcoma
Gabriel Tinoco 16
Very early researchStudy completedNCT04724473
What this trial is testing

A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris

Who this might be right for
Acne Vulgaris
Sun Pharmaceutical Industries, Inc. 1,030
Testing effectiveness (Phase 2)Study completedNCT02279095
What this trial is testing

An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 58
Testing effectiveness (Phase 2)Study completedNCT00382200
What this trial is testing

Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00003656
What this trial is testing

Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Weill Medical College of Cornell University 26
Testing effectiveness (Phase 2)Study completedNCT02278861
What this trial is testing

Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis

Who this might be right for
Actinic Keratosis
Universidade Federal de Goias 60
Early research (Phase 1)Study completedNCT00604032
What this trial is testing

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

Who this might be right for
Healthy
Coria Laboratories, Ltd. 60
Early research (Phase 1)WithdrawnNCT01916187
What this trial is testing

Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma

Who this might be right for
Neuroblastoma
NCIC Clinical Trials Group
Large-scale testing (Phase 3)Study completedNCT01237808
What this trial is testing

Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation

Who this might be right for
Acute Myeloid Leukemia (AML)
University of Ulm 144
Testing effectiveness (Phase 2)Ended earlyNCT00176527
What this trial is testing

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Medicine and Dentistry of New Jersey 40
Testing effectiveness (Phase 2)Study completedNCT00200161
What this trial is testing

Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma

Who this might be right for
GlioblastomaGliomas
Memorial Sloan Kettering Cancer Center 127
Large-scale testing (Phase 3)Study completedNCT00156169
What this trial is testing

The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients.

Who this might be right for
Low HDL Cholesterol
Sheba Medical Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06636981
What this trial is testing

All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Fudan University 129
Not applicableUnknownNCT00939965
What this trial is testing

Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group 75
Testing effectiveness (Phase 2)UnknownNCT03304288
What this trial is testing

The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 168
Post-approval studies (Phase 4)Study completedNCT00952523
What this trial is testing

Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face

Who this might be right for
Acne Vulgaris
Bausch Health Americas, Inc. 162
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation